- Home
- Publications
- Publication Search
- Publication Details
Title
Novel Treatments in Lupus
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-11-16
DOI
10.3389/fimmu.2018.02658
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ofatumumab for B cell depletion in patients with systemic lupus erythematosus who are allergic to rituximab
- (2018) Sherry Masoud et al. RHEUMATOLOGY
- Efficacy and Safety of Subcutaneous Belimumab in Anti-Double-Stranded DNA-Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus
- (2018) A. Doria et al. Arthritis & Rheumatology
- Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study
- (2016) Munther Khamashta et al. ANNALS OF THE RHEUMATIC DISEASES
- A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE)
- (2015) Kenneth C Kalunian et al. ANNALS OF THE RHEUMATIC DISEASES
- Further thoughts about the ILLUMINATE studies of tabalumab in SLE
- (2015) David Isenberg ANNALS OF THE RHEUMATIC DISEASES
- Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
- (2015) Jan A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Blockade of Interferon-γ Normalizes Interferon-Regulated Gene Expression and Serum CXCL10 Levels in Patients With Systemic Lupus Erythematosus
- (2015) Andrew A. Welcher et al. Arthritis & Rheumatology
- Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up
- (2014) Chi Chiu Mok et al. ANNALS OF THE RHEUMATIC DISEASES
- Dual Functions of Bruton's Tyrosine Kinase and Tec Kinase during Fc Receptor-Induced Signaling and Phagocytosis
- (2014) J. Jongstra-Bilen et al. JOURNAL OF IMMUNOLOGY
- Expanded Double Negative T Cells in Patients with Systemic Lupus Erythematosus Produce IL-17 and Infiltrate the Kidneys
- (2014) J. C. Crispin et al. JOURNAL OF IMMUNOLOGY
- IL-2 Protects Lupus-Prone Mice from Multiple End-Organ Damage by Limiting CD4−CD8−IL-17–Producing T Cells
- (2014) Masayuki Mizui et al. JOURNAL OF IMMUNOLOGY
- Selective Inhibition of BTK Prevents Murine Lupus and Antibody-Mediated Glomerulonephritis
- (2013) A. L. Rankin et al. JOURNAL OF IMMUNOLOGY
- Treatment with Anti-Interleukin 23 Antibody Ameliorates Disease in Lupus-Prone Mice
- (2013) Vasileios C. Kyttaris et al. Biomed Research International
- Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
- (2012) George K Bertsias et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double-blind, placebo-controlled trial
- (2012) Zhi-Wei Lai et al. ARTHRITIS AND RHEUMATISM
- Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
- (2012) Roy Fleischmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Beneficial effect of novel proteasome inhibitors in murine lupus via dual inhibition of type I interferon and autoantibody-secreting cells
- (2011) H. Travis Ichikawa et al. ARTHRITIS AND RHEUMATISM
- Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
- (2011) John Koreth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cutting Edge: IL-23 Receptor Deficiency Prevents the Development of Lupus Nephritis in C57BL/6-lpr/lpr Mice
- (2010) V. C. Kyttaris et al. JOURNAL OF IMMUNOLOGY
- The Role of IL-23/IL-17 Axis in Lupus Nephritis
- (2009) Z. Zhang et al. JOURNAL OF IMMUNOLOGY
- Activation of Mammalian Target of Rapamycin Controls the Loss of TCR in Lupus T Cells through HRES-1/Rab4-Regulated Lysosomal Degradation
- (2009) D. R. Fernandez et al. JOURNAL OF IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started